STAAR Surgical (STAA) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.19
- Estimate
- $0.17
- Surprise
- +15.1%
- Revenue (period 2026-10-02)
- $83.4M
- Score today
- 6.6/10
Revenue source: xbrl.
How the report landed
STAAR Surgical (STAA) beat the $0.17 estimate with adjusted EPS of $0.19 — a large 15.1% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates STAA Hold at 6.6/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +15.1% surprise compares with a +49.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Geographic: outside the United States (91.0%)
- Concentration risk — Product: ICLs (100.0%)
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $27.17
- Stop
- $25.27
The stock trades at 339.6× trailing but 24.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 75 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 1.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.
STAA at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $1.36B
- P/E (fwd)
- 24.4
- P/E (ttm)
- 339.6
- 52-week range
- $15.59–$35.87
- Off 52-week high
- 24.3%
- RSI (14)
- 75
- Volume vs avg
- 1.66×
- Score today
- 6.6/10